Your browser doesn't support javascript.
loading
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
Cardoso, F; Senkus, E; Costa, A; Papadopoulos, E; Aapro, M; André, F; Harbeck, N; Aguilar Lopez, B; Barrios, C H; Bergh, J; Biganzoli, L; Boers-Doets, C B; Cardoso, M J; Carey, L A; Cortés, J; Curigliano, G; Diéras, V; El Saghir, N S; Eniu, A; Fallowfield, L; Francis, P A; Gelmon, K; Johnston, S R D; Kaufman, B; Koppikar, S; Krop, I E; Mayer, M; Nakigudde, G; Offersen, B V; Ohno, S; Pagani, O; Paluch-Shimon, S; Penault-Llorca, F; Prat, A; Rugo, H S; Sledge, G W; Spence, D; Thomssen, C; Vorobiof, D A; Xu, B; Norton, L; Winer, E P.
Afiliación
  • Cardoso F; European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
  • Senkus E; European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Costa A; European School of Oncology, Milan, Italy.
  • Papadopoulos E; Europa Donna Cyprus, Nicosia, Cyprus.
  • Aapro M; Oncology Department, Clinique de Genolier, Genolier, Switzerland.
  • André F; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Harbeck N; Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany.
  • Aguilar Lopez B; Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico.
  • Barrios CH; Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil.
  • Bergh J; Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden.
  • Biganzoli L; European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy.
  • Boers-Doets CB; CB Boers Organization, Wormer, The Netherlands.
  • Cardoso MJ; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal.
  • Carey LA; Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.
  • Cortés J; Department of Oncology, Vall d' Hebron University, Barcelona, Spain.
  • Curigliano G; Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy.
  • Diéras V; Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France.
  • El Saghir NS; Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
  • Eniu A; Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
  • Fallowfield L; SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
  • Francis PA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Gelmon K; Medical Oncology Department, BC Cancer Agency, Vancouver, Canada.
  • Johnston SRD; Department of Medicine, The Royal Marsden, Sutton, UK.
  • Kaufman B; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Koppikar S; Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India.
  • Krop IE; Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA.
  • Mayer M; Advanced BC.org, New York, USA.
  • Nakigudde G; Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda.
  • Offersen BV; European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Ohno S; Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan.
  • Pagani O; Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland.
  • Paluch-Shimon S; Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel.
  • Penault-Llorca F; Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France.
  • Prat A; IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain.
  • Rugo HS; Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Sledge GW; Oncology Division, Stanford University Medical Center, Stanford, USA.
  • Spence D; Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia.
  • Thomssen C; Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany.
  • Vorobiof DA; Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa.
  • Xu B; Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
  • Norton L; Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York.
  • Winer EP; Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA.
Ann Oncol ; 29(8): 1634-1657, 2018 08 01.
Article en En | MEDLINE | ID: mdl-30032243

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Conferencias de Consenso como Asunto / Oncología Médica Tipo de estudio: Diagnostic_studies / Guideline Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Conferencias de Consenso como Asunto / Oncología Médica Tipo de estudio: Diagnostic_studies / Guideline Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article